136 related articles for article (PubMed ID: 8897568)
1. Influence of enalapril on experimental cyclosporin A nephrotoxicity.
Anarat A; Noyan A; Gonlusen G; Duman N; Tuncer D
Pediatr Nephrol; 1996 Oct; 10(5):616-20. PubMed ID: 8897568
[TBL] [Abstract][Full Text] [Related]
2. Effects of combination of cyclosporine with losartan or enalapril on kidney function in uremic rats.
Azzadin A; Małyszko J; Małyszko JS; Tankiewicz A; Myśliwiec M; Buczko W
Pol J Pharmacol; 2002; 54(5):469-73. PubMed ID: 12593533
[TBL] [Abstract][Full Text] [Related]
3. Effects of STZ-induced diabetes and its treatment with vanadyl sulphate on cyclosporine A-induced nephrotoxicity in rats.
Saad SY; Najjar TA
Arch Toxicol; 2005 Sep; 79(9):493-9. PubMed ID: 15940472
[TBL] [Abstract][Full Text] [Related]
4. Toxic effect of concomitant administration of cyclosporin A and acyclovir on renal function and morphology in rats.
Hannemann J; Wunderle W; Yousif T; Krüger S; Baumann K
Arch Toxicol; 1997; 71(9):556-62. PubMed ID: 9285038
[TBL] [Abstract][Full Text] [Related]
5. Enalaprilat directly ameliorates in vitro cyclosporin nephrotoxicity in human tubulo-interstitial cells.
Johnson DW; Saunders HJ; Vesey DA; Qi W; Field MJ; Pollock CA
Nephron; 2000 Dec; 86(4):473-81. PubMed ID: 11124597
[TBL] [Abstract][Full Text] [Related]
6. Enalapril in subantihypertensive dosage attenuates kidney proliferation and functional recovery in normotensive ablation nephropathy of the rat.
Krivosíková Z; Sebeková K; Spustová V; Lajdová I; Dzúrik R
Physiol Res; 1999; 48(6):429-35. PubMed ID: 10783907
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of oral L-arginine supplementation on cyclosporine induced nephropathy in rats.
Kuruş M; Eşrefoğlu M; Bay A; Oztürk F
Int Urol Nephrol; 2005; 37(3):587-94. PubMed ID: 16307347
[TBL] [Abstract][Full Text] [Related]
8. An interleukin-6-neutralizing antibody prevents cyclosporine-induced nephrotoxicity in mice.
LaSpina M; Tripathi S; Gatto LA; Bruch D; Maier KG; Kittur DS
J Surg Res; 2008 Aug; 148(2):121-5. PubMed ID: 18561950
[TBL] [Abstract][Full Text] [Related]
9. Light microscopic and electron microscopic features of cyclosporine nephrotoxicity in rats.
Kim JY; Suh KS
J Korean Med Sci; 1995 Oct; 10(5):352-9. PubMed ID: 8750061
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity.
Capasso G; Unwin R; Ciani F; Rizzo A; Russo F; Pica A; De Santo NG
Nephron; 2000 Nov; 86(3):298-305. PubMed ID: 11096287
[TBL] [Abstract][Full Text] [Related]
11. Two good reasons for an angiotensin-II type 1 receptor blockade with losartan after cardiac transplantation: reduction of incidence and severity of transplant vasculopathy.
Richter MH; Richter HR; Olbrich HG; Mohr FW
Transpl Int; 2003 Jan; 16(1):26-32. PubMed ID: 12545338
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin-tacrolimus and simvastatin-cyclosporin interactions in rats.
Yamada H; Kotaki H; Sawada Y; Iga T
Biopharm Drug Dispos; 1998 Jul; 19(5):279-84. PubMed ID: 9673778
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II regulation of vascular endothelial growth factor and receptors Flt-1 and KDR/Flk-1 in cyclosporine nephrotoxicity.
Shihab FS; Bennett WM; Isaac J; Yi H; Andoh TF
Kidney Int; 2002 Aug; 62(2):422-33. PubMed ID: 12110003
[TBL] [Abstract][Full Text] [Related]
14. Normal renal function 8 to 13 years after cyclosporin A therapy in 285 diabetic patients.
Assan R; Blanchet F; Feutren G; Timsit J; Larger E; Boitard C; Amiel C; Bach JF
Diabetes Metab Res Rev; 2002; 18(6):464-72. PubMed ID: 12469360
[TBL] [Abstract][Full Text] [Related]
15. The influence of enalapril or spironolactone on experimental cyclosporin nephrotoxicity.
McAuley FT; Whiting PH; Thomson AW; Simpson JG
Biochem Pharmacol; 1987 Mar; 36(5):699-703. PubMed ID: 3030332
[TBL] [Abstract][Full Text] [Related]
16. Long-term cyclosporin A nephrotoxicity in the rat. Evaluation of a morphological scoring system and of co-treatment with isradipine.
Starklint H; Hansen HV; Kemp M; Leyssac PP; Kemp E; Dieperink H
APMIS; 1994 May; 102(5):347-55. PubMed ID: 8024736
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effect of ubiquinol, the reduced form of coenzyme Q10, on cyclosporine nephrotoxicity.
Ishikawa A; Homma Y
Int Braz J Urol; 2012; 38(2):230-4; discussion 234. PubMed ID: 22555041
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine-loaded polycaprolactone nanoparticles: immunosuppression and nephrotoxicity in rats.
Varela MC; Guzmán M; Molpeceres J; del Rosario Aberturas M; Rodríguez-Puyol D; Rodríguez-Puyol M
Eur J Pharm Sci; 2001 Feb; 12(4):471-8. PubMed ID: 11231114
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine-A induced nephrotoxicity is associated with decreased renal bone morphogenetic protein-7 expression in rats.
Tuğlular S; Gogas Yavuz D; Cakalağaoğlu F; Citak L; Arikan H; Koçak H; Ozener C; Akoğlu E
Transplant Proc; 2004; 36(1):131-3. PubMed ID: 15013323
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of L-propionylcarnitine in chronic cyclosporine-a induced nephrotoxicity.
Origlia N; Migliori M; Panichi V; Filippi C; Bertelli A; Carpi A; Giovannini L
Biomed Pharmacother; 2006 Feb; 60(2):77-81. PubMed ID: 16472963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
